FDA Finds Insufficient Data to Determine Safety of PFAS in Cosmetic Products
Featured image republished from FDA news release. Today, the U.S. Food and Drug Administration today released a congressionally mandated report under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) evaluating the use of perfluoroalkyl and polyfluoroalkyl substances (PFAS) in cosmetic products. While the report reviews available scientific evidence on potential safety concerns, the FDA’s…
